← Human Trials & Peer-Reviewed Studies

Intermittent antegrade hyperkalaemic warm blood cardioplegia supplemented with magnesium prevents myocardial substrate derangement in patients undergoing coronary artery bypass surgery.

Plain-language guide to PMID 9879871 (1998): randomized controlled trial of Vitamin D, K2, Magnesium and Zinc.

Key Facts

PMID
9879871
Journal
European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
Year
1998
Study type
Randomized Controlled Trial
Authors
Caputo M et al. (5 authors)
DOI
10.1016/s1010-7940(98)00247-4

What This Study Did, in Plain Language

What Was Tested

The paper reports a study of Vitamin D, K2, Magnesium and Zinc, published as a randomized controlled trial.

The influence of the addition of magnesium on myocardial protection with intermittent antegrade warm blood hyperkalaemic cardioplegia in patients undergoing coronary artery surgery was investigated and compared with intermittent antegrade warm blood hyperkalaemic cardioplegia only.

Who Took Part

The age groups tagged for this paper are middle-aged adults, both men and women.

Twenty-three patients undergoing primary elective coronary revascularization were randomized to one of two different techniques of myocardial protection.

How the Study Was Run

The researchers set it up as a randomized study.

Because people in this Vitamin D, K2, Magnesium and Zinc study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.

In the first group, myocardial protection was induced using intermittent antegrade warm blood hyperkalaemic cardioplegia.

In the second group, the same technique was used except that magnesium was added to the cardioplegia.

Intracellular substrates (ATP, lactate and amino acids) were measured in left ventricular biopsies collected 5 min after institution of cardiopulmonary bypass, after 30 min of ischaemic arrest and 20 min after reperfusion.

What Was Measured

The subject headings attached to it are Adenosine Triphosphate, Amino Acids, Biopsy, Blood, Calcium Channel Blockers, Cardioplegic Solutions and Coronary Artery Bypass.

What This Means in Plain Language

The paper is a randomized study of Vitamin D, K2, Magnesium and Zinc.

The abstract goes on to report its results in about 4 sentences; this page does not restate them, so read the paper for the findings and their limits.

The publication is from 1998 (European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery), a journal based in Germany.

More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.

Our Notes on the Compound

Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.

Related Pages

Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.